Research and Markets: Herpes Labialis (Oral Herpes) Pipeline Insights

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/5fxzkr/herpes_labialis) has announced the addition of the "Herpes Labialis (Oral Herpes)-Pipeline Insights" report to their offering.

Herpes Labialis (Oral Herpes) Pipeline Insights provides the in-depth analysis of the pipeline assets across the Herpes Labialis (Oral Herpes). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Herpes Labialis (Oral Herpes) Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

Herpes Labialis (Oral Herpes) Pipeline Insights Report covers the Herpes Labialis (Oral Herpes) pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Herpes Labialis (Oral Herpes) related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Herpes Labialis (Oral Herpes).

Scope

- The report provides a Herpes Labialis (Oral Herpes) Landscape across the globe

- The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information

- Coverage of the Herpes Labialis (Oral Herpes) pipeline on the basis of target, MOA, route of administration, technology involved and molecule type

- The report reviews key players involved in the therapeutics development for Herpes Labialis (Oral Herpes) and also provide company profiling

- Pipeline products coverage based on various stages of development from NDA filings to discovery.

- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

For more information visit http://www.researchandmarkets.com/research/5fxzkr/herpes_labialis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals